CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Pfizer posts late-stage trial wins for Litfulo in vitiligo

Phase 3positiveLitfuloPositive
AI Analysis

Summary

Pfizer announced positive Phase 3 trial results for Litfulo in vitiligo treatment. The late-stage trial success represents a key milestone for the drug candidate.

Clinical Trial Data

Phase

3

Primary Endpoint

Met

Importance:7/10
Sentiment:
0.80
Phase_3_datavitiligopositive_trial_results
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 30, 2026 12:20 PM

Read Original